<p>The present disclosure relates to antibodies directed to the tumor necrosis factor alpha ("TNF-a") and uses of such antibodies, for example, to treat diseases associated with the activity and/or overproduction of TNF-a.</p>
申请公布号
WO2010121140(A1)
申请公布日期
2010.10.21
申请号
WO2010US31406
申请日期
2010.04.16
申请人
FACET BIOTECH CORPORATION;HARDING, FIONA, A.;AKAMATSU, YOSHIKO;DUBRIDGE, ROBERT, B.;POWERS, DAVID, B.
发明人
HARDING, FIONA, A.;AKAMATSU, YOSHIKO;DUBRIDGE, ROBERT, B.;POWERS, DAVID, B.
